Evidence map›Paper›PMID 25770173›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2015

Treatment to Prevent HIV Transmission in Serodiscordant Couples in Henan, China, 2006 to 2012.

M Kumi Smith, Daniel Westreich, Huixin Liu, Lin Zhu, Lan Wang, Wensheng He, Jianping Zhou, William C Miller, Myron S Cohen, Ning Wang

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Female Condom Use and Its Acceptability Among HIV-serodiscordant Couples in China.The Journal of the Association of Nurses in AIDS Care : JANAC
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

M Kumi SmithDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill National Center for AIDS/STD Control and Prevention.
Daniel WestreichDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill.
Huixin LiuNational Center for AIDS/STD Control and Prevention.
Lin ZhuNational Center for AIDS/STD Control and Prevention.
Lan WangNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing.
Wensheng HeZhumadian Centre for Disease Control and Prevention, Henan Province, China.
Jianping ZhouZhumadian Centre for Disease Control and Prevention, Henan Province, China.
William C MillerDepartment of Medicine, School of Medicine, University of North Carolina at Chapel Hill.
Myron S CohenDepartment of Medicine, School of Medicine, University of North Carolina at Chapel Hill.
Ning WangNational Center for AIDS/STD Control and Prevention.
National Center for AIDS/STD Control and Prevention,China CDC · CNUniversity of North Carolina at Chapel Hill · USNational Institute for Communicable Disease Control and Prevention · CN

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Training in Sexually Transmitted Infections and HIVT32AI007001 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SENA-SOBERANO, ARLENE C. · 1985 to 2025
$10.9M
Johns Hopkins HIV Epidemiology and Prevention Sciences Training ProgramT32AI102623 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Shruti H Mehta · 2013 to 2026
$5.3M
NIAID NIH HHS P30 AI050410NIAID NIH HHS P30 AI50410NIAID NIH HHS T32 AI007001NIAID NIH HHS T32 AI102623
6 · The paper itself

Abstract

backgroundAntiretroviral therapy (ART) administered in clinical trial settings virtually eliminates the sexual transmission of human immunodeficiency virus (HIV) in serodiscordant couples, but effectiveness of treatment as prevention in the community is debated. Conflicting results from previous analyses in a Chinese cohort underscore the importance of determining effectiveness of ART delivered in resource limited settings.

methodsAll available years of data (2006-2012) from local disease control records of HIV patients and their seronegative spouses in Henan Province, China, were analyzed using marginal structural Cox models to estimate the effect of ART in the initially infected partner his or her partner's HIV seroconversion risk.

resultsWe observed 157 seroconversion events in 4916 serosdiscordant couples, for an incidence rate of 0.59 cases per 100 person-years (PY) (95% confidence interval [CI], .51-.70). Of these, 84 occurred after the index partner had initiated ART (0.43/100PY; 95% CI, .35-.53) and 73, whereas index partners were untreated (5.87/100 PY; 95% CI, 4.65-7.42). In a marginal structural Cox model weighted for confounding and censoring, the hazard ratio (HR) for HIV transmission was 0.52 (95% CI, .34-.82). ART efficacy varied significantly by time period; least effective in the early phase from 2006 to 2008 (HR, 0.68; 95% CI, .34-1.36) but far more protective from 2009 onward (HR, 0.33; 95% CI, .20-.55).

conclusionsART can provide HIV-infected persons in resource-limited setting substantial protection against sexual transmission. Effectiveness in the Henan cohort appears to have increased over time, suggesting that quality of care and service infrastructure may be integral to successful use of treatment for prevention.

Indexed as

Family CharacteristicsAdultAnti-Retroviral AgentsChinaCohort StudiesDisease Transmission, InfectiousFemaleHIV InfectionsHumansIncidenceMaleMiddle AgedRisk AssessmentAnti-Retroviral AgentsChinaHIV/AIDSHIV treatment as preventionserodiscordant couplessexual transmission

Identifiers

PMID25770173
PMCPMC4542909
OpenAlexW2123823005

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.